March 21, 2000Merck and Company Recalls
Decadron Phosphate Injection
West Point, PA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Merck and Company is recalling Decadron(r)
Phosphate Injection because of product degradation at 12-month stability. (single
According to the FDA, approximately
51,000 vials of Decadron(r) Phosphate Injection (Dexamethasone Sodium Phosphate), USP, 4
mg per 5 ml injection (NDC #0006-7268-03), were distributed nationwide.
The recalled products have the lot
numbers of 0580H, 0874H, 1476H, 0051J, 0329J, and 1577H.
This ongoing Class III recall
was initiated by Merck and Company, by letter dated February 17, 2000. This is the
first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-253-0
Notice of this product warning was
sent via email to SafeMail
subscribers March 21, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.